The overall biotech market is looking up, but in the ever-changing healthcare landscape, some areas are always hotter than others. At the height of the pandemic, for example, digital health and telehealth became booming industries. But now there are new players in town, reports Cure's Ready, Set, Growth! Biotech Benchmark Report 2024 survey. 

Pharma molecules biotech

The New Players in Town

Please join us for Tuesday Talks on October 8th at 12:30pm EDT to watch an insightful conversation with a prominent figure in AI drug discovery. Alex Zhavoronkov, the CEO of Insilico Medicine, will be sharing his latest clinical research findings, discussing upcoming products, and elucidating his company's application of Generative AI in shaping the future of medicine. 

Tuesday Talk Generative AI & The Future of Medicine Headshot

Generative AI & The Future of Medicine

Daniel Kraft, MD, Founder and Chair of ‪@NextMedHealth‬, discusses what’s Now, Near, and Next in rapidly evolving technologies, from AI, Big Data, and Virtual Reality to Robotics, Synthetic Biology, and Low-Cost Omics. 

Tuesday Talks: What’s Now, Near & Next in Health Tech?

Blue

Insilico Medicine is revolutionizing drug discovery for mesothelioma and other solid tumors with its generative AI engine .

Insilico Inks Exclusive License for Anti-Cancer Molecule

The successful treatment of patients with IBD, such as ulcerative colitis or Crohn's disease, might be transformed by Insilico’s ISM5411.



AI-Designed Therapy for Inflammatory Bowel Disease Advances

As artificial intelligence changes health, environmental tech and robotics, experts predict longer lives, cleaner air and humanoids

How will AI Transform the Way We Live and Breathe

Manolis Kellis, PhD, discusses how artificial intelligence is transforming the very nature of medicine. 

Big genomic data visualization

Outside Lander's Office: From DNA Sequencing to AI Insights 

What obstacles must be overcome for disruptive tools like AI, VR and robotics to reshape healthcare as we know it? Daniel Kraft, MD, explains.

Unlocking the Future of Healthcare: How AI, VR, and Robotics will Reshape Medicine

Five science and industry experts shared their predictions during #GenAI4Pharma NYC on how AI will transform life science research to save time, money — and lives. 

Near-Future Promises for Healthcare AI, According to 5 Experts Image

Near-Future Promises for Healthcare AI, According to 5 Experts

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, presents the keynote at the #GenAI4Pharma at Cure.

thumbnail-alex-zhavoronkov-genai4pharma

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, to Address #GenAI4Pharma Showcase at Cure

Shwen Gwee, digital health and corporate innovator, created #GenAI4Pharma to help biopharma adopt generative AI and LLM-related tech for every life stage of new therapies.

thumbnail-genai4pharma-article

6 Things to Know about #GenAI4Pharma

Oben Health is improving care access using AI to facilitate screenings, education and connections to treatment in nontraditional spaces like barbershops, havens of support especially in communities of color.



thumbnail-oben-health-barbershop-model

Delivering Healthcare in Places of Trust: The Oben Health Barbershop Model

Most biomedical researchers agree that the promise of AI for the future drug discovery is likely to be extraordinary. What can we expect in the  next decade?

thumbnail_five_ways_AI_influence_drug_discovery

Five Ways AI May Influence the Future of Drug Discovery

Eyal Zimlichman, MD, founder of the ARC Innovation Center at Sheba Medical Center, the Middle East’s largest healthcare system, brings players in digital medicine together with external partners to accelerate change in healthcare on a global scale.

Insight Article Eyal Zimlichman Thumbnail July 2024

Sheba ARC’s Eyal Zimlichman Driving Systemic Change in Healthcare 

In the world of drug discovery, AI engenders feelings of hope, excitement and optimism. Indeed, machine learning algorithms already accelerate discovery, improve efficiency, reduce costs and even save lives.

NYAS

Inspiring Hope, Not Fear:  How AI is Already Transforming Drug Discovery

Cure® and The New York Academy of Sciences to Co-Host Forum on Science and Business of AI-Driven Drug Discovery

Isolated RNA

Overriding the Cellular Code with mRNA to Fight Cancer

Pipetting

Robert Pearl, MD, on the Potential for AI to Revolutionize Healthcare

DNA Profile

3 Changes Genomics Microscopes Bring to Understanding Disease

Cure® Unveils US Biotech Industry Benchmark Report 2024: Dark Days of 2023 are Over

Computer Screens with DNA

From Clinic to Climate: Insilico’s Alex Zhavoronkov Talks AI

Industrial Molecular Revolution

What is the Molecular Industrial Revolution?

The Passion of a Liver Doctor -- Maliha Ahmad MD

Fighting Liver Disease with Detection, AI and Novel Therapies 

Paris-based Wandercraft unveils a next generation exoskeleton to assist disabled people — part of a surge in “exo-tech” that is also raising the specter of wearable robots that could enhance everyone.

Wandercraft -- Robot-Human Hybrids Are Here

Robot-Human Hybrids are Here

How Life Science Companies Use AI to Target Investors

Investing in AI for Drug Discovery: Capital, Data and Safety

What Will It Take to Deliver Cures to Society?

How can AI advance healthcare? Michael Montello, MBA, GSK’s Senior Vice President for R&D Digital and Tech Tech, shares insights into the top six areas of AI’s impact on healthcare.

At the Intersection of Healthcare, Data and Tech: Leveraging AI for Good

Compared to life-threatening conditions like cancer, inflammatory and immune system diseases are understudied, yet they diseases are common and seriously affect patients' quality of life. Gregory S. Moss, Esq., Chief Corporate Strategy and Legal Officer at Evommune, a company advancing therapies for chronic inflammatory diseases, shares his insights.

Drug Development for Inflammatory Diseases Comes of Age

Five startup companies have won the inaugural Cure Xchange Challenge: Health AI for Good. Allagi.ai, BioCurie, Deepecho, Every Cure and Oben Health will receive one-year residencies at Cure’s innovation campus in New York City along with unrestricted seed grants, mentoring, in-kind resources and support services from Cure’s partners, including Amazon Web Services, ThermoFisher and NVIDIA.

2/22/2024 CURE Xchange Challenge 343
Group: Winners and advisors
Size: 1920x1080
Photog: Fernando Colon

Five Winners of Cure Xchange Challenge: Health AI For Good Announced

Cure® Announces Five Winners of Cure Xchange Challenge: Health AI For Good

When he was a little boy, Collins “Collogh” Oghor lost his aunt to kidney failure, and now, having earned an MD, MBA, and MPH, he has developed an AI solution to help healthcare providers battle this devastating — and preventable — disease.

Cure Xchange Challenge Finalist Collogh Cares logo

Collogh Cares Logo

Spotlight On: Collogh Cares Co-founder Collins Oghor, MD, MBA, MPH

Driven to help people in marginalized communities get the healthcare they deserve, Jonathan Govette and his co-founders developed an AI solution for identifying people at high risk for lung cancer, so they can get treated early — saving both money and lives.

Cure Xchange Challenge Finalist Oatmeal Health logo

Oatmeal Health Logo

Spotlight On: Oatmeal Health Co-founder Jonathan Govette

With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.

Cure Xchange Challenge Finalist BioCurie logo

BioCurie Logo

Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie

As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.

Cure Xchange Challenge Finalist Deepecho logo

Deepecho Logo

Spotlight On: Saad Slimani, MD, MS,  Co-founder of Deepecho

As an ER nurse, Kwamane Liddell, JD, MHA, BSN, encountered many low-income families whose language barriers kept them from taking advantage of nutritious food assistance programs. He realized AI could help these families successfully access not only nutrition but also medicine, housing, and even health insurance.

ThriveLink Logo

Spotlight On: Kwamane Liddell, JD, MHA, Co-founder ThriveLink (formerly Nutrible) 

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  

Spotlight On_Grant_Mitchell_Image

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

Through his company Allagi.ai, Alex Gavryushkin, PhD, is using AI to streamline a time-consuming process for oncologists, allowing them to devise more effective treatment plans for patients, including those with rare and hard-to-treat cancers.

Cure Xchange Challenge Finalist Allagi.ai logo

Allagi.ai

Spotlight On: Alex Gavryushkin, Founder of Allagi.ai

AI engineer Robhy Bustami grew up in a family of obstetricians. His knowledge of the challenges around access to quality maternal medicine led him to develop an ultrasound technology solution poised to improve the health of families in underserved communities worldwide.

Cure Xchange Challenge Finalist Biotics.ai logo

BioticAI

Spotlight On: Robhy Bustami, Co-founder of BioticsAI

After the sudden death of his older brother from hypertension, Peter Njongwe launched a company that marries cutting-edge AI technology with friendly neighborhood barbershops. It’s an innovative approach to getting hesitant populations to embrace the healthcare they need.

Cure Xchange Challenge Finalist Oben Health logo

Oben Health 

Spotlight On: Peter Njongwe, Co-founder of Oben Health 

Microsoft Chief Medical Officer David Rhew, MD, gets beyond the hype on the value of generative artificial intelligence (AI)  in healthcare today.

From Administrative Tasks to Drug Discovery, AI is Poised to Transform Healthcare

Cure® Announces 10 Finalists for Cure Xchange Challenge: Health AI For Good

Cure® Opens Applications To Cure Xchange Challenge Focused On “Health AI For Good”

Cure® Hosts "AI for Good" Super Session to Make Sense of Big Data and High Tech at 2023 BIO International Convention on June 5

Governor Hochul Announces $50 Million Preclinical Drug Discovery "Lab of the Future" in New York City

Insights

Xchange Challenge winners and co-founders Grant W. Mitchell MD, MBA, and David Fajgenbaum, MD, MBA, MSc from Every Cure join Tuesday Talks. Learn about their groundbreaking AI-powered platform that offers solutions for rare disease treatments and cures—a capability beyond the reach of many medical experts today. We'll delve into how their $48.3 million government grant will be fueling meaningful advancements, Fajgenbaum's personal victory over his rare disease, and the company's patient-first approach at their new Cure NYC headquarters.


AI & The Future of Cures

Cure CEO Seema Kumar sits down with Alex Zhavoronkov, PhD, Chairman and CEO of Insilico Medicine, discussing how generative AI is transforming and accelerating drug discovery.

Cure Tuesday Talks Alex Zhavoronkov banner image

Learning AI for Every Step of Pharma R&D

Irene Rombel PhD, MBA, the visionary co-founder and CEO of BioCurie and winner of the Cure Xchange Challenge: Health AI for Good. We’ll discuss her career path from professor to investor and now CEO of an early-stage biotech company harnessing Al to transform cell and gene therapy manufacturing.

Pioneering BioCurie's Vision

Joe Wilson, MBA, Founder and Managing Partner at Undeterred Capital in Los Angeles, talks about the trends in using AI for drug discovery and what investors are looking for in early stage life science companies.

Cure Tuesday Talks Joe Wilson banner image

How Life Science Companies Use AI to Target Investors 

A discussion of the trends in science and inclusion from three leading global figures in communicating science and technology. This special Tuesday Talk was part of the 2023 UN Science Summit, held at Cure. 

Cure Tuesday Talks The Future of Science and Inclusivity thumbnail image

The Future of Science & Inclusivity

Michael Montello, MBA, discusses NASA, AI and pharma’s transition to using big data and modeling to boost the probability of success of new medicines and vaccines.

Cure Tuesday Talks banner image Michael Montello

How GSK is Powering R&D with Data, Digital and Tech

Mary Woolley, CEO of Research!America, is a passionate advocate for the critical role of science and technology in society, and for 30 years has been an inspiring leader in promoting women in science. 

Cure Tuesday Talks Mary Woolley banner image

How Critical is Research and Technology to the Future - and Women's Role Within It?

Physician-scientist-executive Judith Absalon, MD, discusses her experience conducting clinical trials during the COVID-19 pandemic and the current environment. 


Cure Tuesday Talks banner image Judith Absalon 

From Pharma’s Front Lines: Infectious Disease, Vaccines and the Future

CEO & Co-Founder Maria Luisa Pineda, PhD, of Envisagenics discusses how she brings her passion of culture and diversity to the NYC biopharma community.


Cure Tuesday Talks banner image Maria Luisa Pineda

Exploring Culture and Diversity in BioPharma

Join Seema Kumar, CEO of Cure and Michael Foley, CEO of Deerfield Discovery & Development, for an evening of groundbreaking keynotes by two leading scientists: Bartosz Grzybowski, PhD, and Marty Burke, PhD. These two luminaries are applying AI, advanced synthetic chemistry, and decades of accumulated knowledge of functional molecules to advance the field of small molecule chemistry. They will discuss applications of their work in case studies that demonstrate the power of innovation in the fields of drug discovery, global chemical production, and national (bio)chemical security.

Welcome to the Molecular Industrial Revolution

Join Seema Kumar, the CEO of Cure, for an exclusive live announcement of the winners of the Cure Xchange Challenge: Health AI For Good, which is being held in partnership with the Clinton Foundation. John Mattison, MD, will provide a short keynote talk on the latest developments in AI in science, before Chelsea Clinton, DPhil, presents the awards to the winners. The Xchange Challenge winners will also present summaries of their companies and projects during the event.


Special Award Presenter: Chelsea Clinton DPhil, MPH, Clinton Foundation
Keynote: John Mattison, MD, Assistant Medical Director and Chief Medical Information Officer at Kaiser Permanente

Cure XChange Challenge Winner Announcement

Tuesday_talks_thumbnail_NYAS_AI_driven_drug_development

The Science and Business of AI-Driven Drug Discovery   

Events

Become a member of Cure and help shape the future of healthcare.

Join our community

Regular

345 Park Avenue South

Xchange Challenge

All floors are lab-ready and cabled for digital health.

Community

Residents

Leadership

Be part of *Cure.*

Orange

Where scientists, entrepreneurs and visionaries converge.

Campus

Ecosystem

Event Spaces

Gallery

Space Availability

A place to *Succeed.*

Green

Joe Wilson How Life Sciences Companies Use AI to Target Investors Mega Menu Image 

Critical Discussions Advancing Healthcare

Upcoming Events

Event Inquiry

Past Events

Speakers

Tuesday Talks

Cure *Events.*

Magenta

Cure Clips

Tuesday Talks Series

Cure *Tuesday Talks*

Two awards up to $250,000

Partnerships and Sponsorships

Women in Science

XSeed Award

Connect with *Opportunity.*

Network

Cure Insights Article A Bionic Pancreas that will Help Parents Sleep More Peacefully image for Cure Insights Mega Menu.  Image credit Cottonbro Studio.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

AI and Machine Learning

Insights

Events

Recommended Topics

Join our community

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

AI and Machine Learning

Insights

Events

Recommended Topics

Join our community

Cure Events.

Cure Tuesday Talks

In-depth Insights.